Albert Hietala

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JAMA NEUROLOGY. 2022;79(11):1105-1112
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial
Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Hakansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundstrom P; Wickberg O; Brauner S; Frisell T
Article: JAMA NEUROLOGY. 2020;77(8):974-981
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
Article: NEUROLOGY: NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2020;7(4):e775
Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
Duell F; Evertsson B; Al Nimer F; Sandin A; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;336:577028
Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome
Sveinsson O; Piehl F; Aspegren O; Hietala MA
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2019;36:101414
Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis
Birkeldh U; Manouchehrinia A; Hietala MA; Hillert J; Olsson T; Piehl F; Kockum I; Brundin L; Zahavi O; Wahlberg-Ramsay M; Brautaset R; Nilsson M
Article: NEUROLOGY. 2019;92(23):e2661-e2673
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Howard JFJ; Bril V; Burns TM; Mantegazza R; Bilinska M; Szczudlik A; Beydoun S; De Rivera Garrido FJR; Piehl F; Rottoli M; Van Damme P; Tuan V; Evoli A; Freimer M; Mozaffar T; Ward ES; Dreier T; Ulrichts P; Verschueren K; Guglietta A; de Haard H; Leupin N; Verschuuren JJGM; Claeys K; Diez-Tejedor E; Mathew V; Sgarzi M; Harvey BL; Farias J; Frangiomore R; Heintzman S; de Meel R; Chopra M; Alboini PE; Hietala A; Genge A
Article: JOURNAL OF MEDICAL CASE REPORTS. 2019;13(1):27
Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report
Bejerot S; Hesselmark E; Mobarrez F; Wallen H; Hietala MA; Nybom R; Wetterberg L
Article: BMJ CASE REPORTS. 2017;2017:bcr-2017-219903
Heroin-induced acute myelopathy with extreme high levels of CSF glial fibrillar acidic protein indicating a toxic effect on astrocytes.
Sveinsson O; Herrman L; Hietala MA
Article: FRONTIERS IN NEUROLOGY. 2017;8:675
The Temporal retinal nerve Fiber layer Thickness is the Most important Optical coherence Tomography estimate in Multiple sclerosis
Birkeldh U; Manouchehrinia A; Hietala MA; Hillert J; Olsson T; Piehl F; Kockum IS; Brundin L; Zahavi O; Wahlberg-Ramsay M; Brautaset R; Nilsson M
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2014;89(3):607-614
Neurochemical Evidence of Potential Neurotoxicity After Prophylactic Cranial Irradiation
Kalm M; Abel E; Wasling P; Nyman J; Hietala MA; Bremell D; Hagberg L; Elam M; Blennow K; Bjork-Eriksson T; Zetterberg H
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2013;169(2):211-215
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission.
Ragnarsson O; Berglund P; Eder DN; Zetterberg H; Hietala MA; Blennow K; Johannsson G
Article: LAKARTIDNINGEN. 2012;109(19):970
[The Swedish Neurological Association: The number of neurologists need to double over the next decade].
Remahl IN; Fredrikson S; Gunnarsson M; Hietala A; Stridh L; Jood K; Burman J; Johansson R; Jensen SM; Petersson J; Zarrinkobb L; Smits A
Article: BRITISH JOURNAL OF SPORTS MEDICINE. 2007;41(9):574-577
No neurochemical evidence for brain injury caused by heading in soccer.
Zetterberg H; Jonsson M; Rasulzada A; Popa C; Styrud E; Hietala MA; Rosengren L; Wallin A; Blennow K
Article: ARCHIVES OF NEUROLOGY. 2006;63(9):1277-1280
Neurochemical aftermath of amateur boxing
Zetterberg H; Hietala MA; Jonsson M; Andreasen N; Styrud E; Karlsson I; Edman A; Popa C; Rasulzada A; Wahlund L-O; Mehta PD; Rosengren L; Blennow K; Wallin A
Article: EMBO JOURNAL. 2006;25(6):1364-1374
Complement: a novel factor in basal and ischemia-induced neurogenesis.
Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson A-K; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
Article: JOURNAL OF NEUROSCIENCE. 2005;25(7):1816-1825
Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation
Nyberg J; Anderson MF; Meister B; Alborn AM; Ström AK; Brederlau A; Illerskog AC; Nilsson O; Kieffer TJ; Hietala MA; Ricksten A; Eriksson PS
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2004;34(4):1208-1216
Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis
Hietala MA; Nandakumar KS; Persson L; Fahlén S; Holmdahl R; Pekna M
Article: JOURNAL OF IMMUNOLOGY. 2002;169(1):454-459
Complement deficiency ameliorates collagen-induced arthritis in mice.
Hietala MA; Jonsson I-M; Tarkowski A; Kleinau S; Pekna M
Article: JOURNAL OF EXPERIMENTAL MEDICINE (JEM). 1999;190(7):915-922
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.
Johansen FE; Pekna M; Norderhaug IN; Haneberg B; Hietala MA; Krajci P; Betsholtz C; Brandtzaeg P
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1998;47(4):375-380
Mice deficient for the complement factor B develop and reproduce normally.
Pekna M; Hietala MA; Landin A; Nilsson AK; Lagerberg C; Betsholtz C; Pekny M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1998;47(1):25-29
Targeted disruption of the murine gene coding for the third complement component (C3).
Pekna M; Hietala MA; Rosklint T; Betsholtz C; Pekny M
Visa fler

Artiklar

Nyheter från KI

Kalenderhändelser från KI